Skip to main content
logo
Indivior Pharmaceuticals, Inc. (INDV)
NASDAQ: INDV · Real-Time Price · USD
40.53
+0.02 (0.04%)
At close: Jul 24, 2026, 4:00 PM EDT
40.35
-0.17 (-0.43%)
Pre-market: Jul 27, 2026, 4:21 AM EDT

Indivior Pharmaceuticals Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1,2911,2391,1881,093901791
Revenue Growth
10.34%4.29%8.69%21.31%13.91%22.26%
Gross Profit
1,049994957919749664
Operating Income
33326238-152-81213
Net Income
2512107-126-44205
Earnings Per Share
9.758.200.25-4.60-1.606.75
EPS Growth
-3180.00%----

Revenue by Geography
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
United States
1,1031,0531,008912732603
Rest of World
187186179181169181
Total
1,2901,2391,1871,093901791

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1751953204108931,102
Total Debt
50935137528300
Net Cash (Debt)
-334-156-551278931,102
Net Cash Growth
----85.78%-18.97%28.44%
Net Cash Per Share
-12.97-6.09-2.074.6432.1236.26

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-111-2736-300-4353
Capital Expenditures
-81-66-29-8-5-4
Free Cash Flow
-192-937-308-9349
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
81.25%80.23%80.56%84.08%83.13%83.94%
Operating Margin
25.79%21.15%3.20%-13.91%-8.99%26.93%
Pretax Margin
22.85%19.29%1.68%-13.27%-9.88%24.02%
Profit Margin
22.85%21.63%2.78%-15.00%-4.99%25.92%
FCF Margin
-14.87%-7.51%0.59%-28.18%-1.00%44.12%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
20.794.3849.72--2.56
Forward PE
10.3012.788.558.9617.0217.57
P/FCF Ratio
--44.97--6.94
PS Ratio
3.830.720.260.380.663.06